ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 25 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $10,000 | -28.6% | 6,149 | -4.7% | 0.01% | -25.0% |
Q1 2017 | $14,000 | -86.3% | 6,449 | -87.9% | 0.01% | -71.4% |
Q4 2016 | $102,000 | +92.5% | 53,422 | +179.7% | 0.04% | +20.0% |
Q3 2016 | $53,000 | +2550.0% | 19,100 | +1369.2% | 0.04% | +3400.0% |
Q2 2016 | $2,000 | – | 1,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Rock Ventures, LLC | 4,841,591 | $78,579,000 | 13.93% |
Flagship Ventures 2007 General Partner LLC | 1,907,008 | $30,951,000 | 13.58% |
Broadfin Capital, LLC | 861,933 | $13,989,000 | 1.36% |
NJ State Employees Deferred Compensation Plan | 25,000 | $406,000 | 0.08% |
SECTORAL ASSET MANAGEMENT INC | 50,000 | $812,000 | 0.03% |
TCW GROUP INC | 105,550 | $1,713,000 | 0.01% |
FRANKLIN RESOURCES INC | 938,100 | $15,225,000 | 0.01% |
State of New Jersey Common Pension Fund A | 75,000 | $1,217,000 | 0.01% |
FMR LLC | 1,614,715 | $26,206,000 | 0.00% |
PRINCIPAL FINANCIAL GROUP INC | 95,300 | $1,547,000 | 0.00% |